Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.46 |
| ▸ | MMP2 | P08253 | 3/20 | 0.46 |
| ▸ | MMP1 | P03956 | 2/20 | 0.46 |
| ▸ | MMP3 | P08254 | 2/20 | 0.46 |
| ▸ | MMP8 | P22894 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PPIP5K2 | O43314 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28801115 | 1.00 | FDPS (0.46) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL16093844 | 1.00 | FDPS (0.46) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL192006 | 1.00 | FDPS (0.46) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL192007 | 1.00 | FDPS (0.46) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL9359318 | 1.00 | FDPS (0.46) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL21359160 | 1.00 | FDPS (0.46) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL23751823 | 0.97 | FDPS (0.43) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL8575235 | 0.97 | FDPS (0.43) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL28610245 | 0.97 | FDPS (0.43) | FDPSMMP2MMP1MMP3MMP8 | |
| Phosphoric Acid SCHEMBL28500444 | 0.97 | FDPS (0.43) | FDPSMMP2MMP1MMP3MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118414344-A | Chemical synthesis of cytidine-5' -monophosphate-N-glycyl-sialic acid | 89生物公司 | 2024-07-30 | — | — | CN | claimed |
| JP-60067424-A | — | — | None | — | — | JP | disclosed |
| CN-120020261-A | Method for total synthesis of N-glycan | 中国科学院上海药物研究所 | 2025-05-20 | — | — | CN | disclosed |
| CN-112513263-B | Method for producing a compound of a foliol | 弗门尼舍有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-118414344-A | Chemical synthesis of cytidine-5' -monophosphate-N-glycyl-sialic acid | 89生物公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-108886175-B | Silicon-based solid electrolyte for rechargeable batteries | 巴斯夫公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-107710462-B | Electrochemical hydrogen storage electrode and battery | 巴斯夫公司 | 2022-08-02 | — | — | CN | disclosed |
| US-11345907-B2 | Method for producing albicanol compounds | FIRMENICH SA (CH) | 2022-05-31 | — | — | US | disclosed |
| US-20220162188-A1 | ISOPRENOIDS AND METHODS OF MAKING THEREOF | NORTH CAROLINA STATE UNIVERSITY | 2022-05-26 | — | — | US | disclosed |
| EP-3911740-A1 | ISOPRENOIDS AND METHODS OF MAKING THEREOF | North Carolina State University (US) | 2021-11-24 | — | — | EP | disclosed |
| US-5668171-A | Halogenated mevalonate compositions and uses thereof in ras-dependent cell growth | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-09-16 | — | — | US | disclosed |
| US-5643958-A | ANTITUMOR | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-07-01 | — | — | US | disclosed |
| EP-0776884-A1 | SUBSTITUTED AMIDE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-06-04 | — | — | EP | disclosed |
| WO-1995013058-A1 | HALOGENATED MEVALONATE COMPOSITIONS AND USES THEREOF IN RAS-DEPENDENT CELL GROWTH | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-05-18 | — | — | WO | disclosed |
| EP-0216855-A4 | RUBBER POLYMERASES AND METHODS FOR THEIR PRODUCTION AND USE. | GOODYEAR TIRE & RUBBER (US) | 1989-04-12 | — | — | EP | disclosed |
| US-4792615-A | HYDROLYSIS OF A-DIHYDROPOLYPRENYL DICHLOROPHOSPHATE WITH ALKALI OR ALKALINE EARTH METAL HYDROXIDE; POLYISOPRENE | NAKAGAWA NAOSHI (JP) | 1988-12-20 | — | — | US | disclosed |
| EP-0216855-A1 | RUBBER POLYMERASES AND METHODS FOR THEIR PRODUCTION AND USE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1987-04-08 | — | — | EP | disclosed |
| US-4638028-A | Rubber polymerases and methods for their production and use | GOODYEAR TIRE & RUBBER COMPANY (US) | 1987-01-20 | — | — | US | disclosed |
| WO-1986006095-A1 | RUBBER POLYMERASES AND METHODS FOR THEIR PRODUCTION AND USE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1986-10-23 | — | — | WO | disclosed |
| JP-S6067424-A | CARCINOSTATIC AGENT | NISSHIN FLOUR MILLING CO LTD | 1985-04-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162188-A1 | ISOPRENOIDS AND METHODS OF MAKING THEREOF | GGPS1, SQLE, FDPS | FDPS 3/4885MMP2 4083/4885MMP1 4385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.